21-CHLORO-9,11-EPOXY-17-HYDROXY-16-METHYL-1,4-;MometasoneFuroateEPImpurityA;MometasoneImpurityA;MometasoneEPImpurityA;MometasoneFuroateImpurity9(MometasoneFuroateEPImpurityA);MoMetasoneFuroateIMpurityChemicalbookA;MometasoneFuroateEPImpurityA/(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-methylpregna-1,4,9(11)-triene-3,20-dione;21-chloro-16α-methyl-17α-hydroxy-1,4,9(11)-pregnatriene-3,20-dione17-(2'-furoate)
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Mometasone Furoate EP Impurity A</strong> is a critical reference standard used in the pharmaceutical industry to ensure the quality of glucocorticoid formulations. Synthesized via specific organic reactions, it serves as an identification and quantification tool for impurities during drug development.</p>
<h3>Application</h3>
<ul>
<li><li>Quality Control: Used in HPLC analysis to detect and quantify trace impurities in Mometasone Furoate APIs.</li>
<li><li>R&D Validation: Essential for method validation and stability testing of dermatological preparations.</li>
<li><li>Regulatory Compliance: Supports submission dossiers for FDA and EMA by characterizing degradation products.</li>
</ul>
<h3>Precautions</h3>
<p>Store strictly below -20°C in a desiccated environment under inert atmosphere. Handle only with appropriate PPE to avoid skin contact; this substance is not intended for direct clinical use or therapeutic administration.</p>